Jeff Yass’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding AVTX
Jeff Yass's AVTX Position: Q3 2026 in Review
Jeff Yass increased its Avalo Therapeutics (AVTX) stake by 1,689% in Q3 2026, buying an estimated $8.46M and bringing the position to 486,975 shares worth $7.47M. The position accounts for ﹤0.01% of the portfolio, ranked #3778.
Jeff Yass first reported a position in AVTX in Q1 2019 and has held it in 17 quarters since. 148 funds tracked by Wall St. Rank hold AVTX as of Q3 2026.
- Jeff Yass held 486,975 shares of Avalo Therapeutics worth $7.47M as of Q3 2026.
- Jeff Yass bought 459,748 Avalo Therapeutics shares in Q3 2026, an estimated $8.46M.
- Avalo Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #3778 holding.
- Jeff Yass first reported a position in Avalo Therapeutics in Q1 2019 and has held it in 17 quarters since.
- 148 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.